Characterization of Inducible Models of Tay-Sachs and Related Disease

English version České info

Tay-Sachs and Sandhoff diseases are lethal inborn errors of acid β-N-acetylhexosaminidase activity, characterized by lysosomal storage of GM2 ganglioside and related glycoconjugates in the nervous system. The molecular events that lead to irreversible neuronal injury accompanied by gliosis are unknown; but gene transfer, when undertaken before neurological signs are manifest, effectively rescues the acute neurodegenerative illness in Hexb−/− (Sandhoff) mice that lack β-hexosaminidases A and B. To define determinants of therapeutic efficacy and establish a dynamic experimental platform to systematically investigate cellular pathogenesis of GM2 gangliosidosis, we generated two inducible experimental models. Reversible transgenic expression of β-hexosaminidase directed by two promoters, mouse Hexb and human Synapsin 1 promoters, permitted progression of GM2 gangliosidosis in Sandhoff mice to be modified at pre-defined ages. A single auto-regulatory tetracycline-sensitive expression cassette controlled expression of transgenic Hexb in the brain of Hexb−/− mice and provided long-term rescue from the acute neuronopathic disorder, as well as the accompanying pathological storage of glycoconjugates and gliosis in most parts of the brain. Ultimately, late-onset brainstem and ventral spinal cord pathology occurred and was associated with increased tone in the limbs. Silencing transgenic Hexb expression in five-week-old mice induced stereotypic signs and progression of Sandhoff disease, including tremor, bradykinesia, and hind-limb paralysis. As in germline Hexb−/− mice, these neurodegenerative manifestations advanced rapidly, indicating that the pathogenesis and progression of GM2 gangliosidosis is not influenced by developmental events in the maturing nervous system.

Vyšlo v časopise: Characterization of Inducible Models of Tay-Sachs and Related Disease. PLoS Genet 8(9): e32767. doi:10.1371/journal.pgen.1002943
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002943

Souhrn

Zdroje

1. TayW (1881) Symmetrical changes in the region of the yellow spot in each eye of an infant. Trans Opthalmol Soc 1: 55–57.

2. SachsB (1887) On arrested cerebral development with special reference to cortical pathology. J Nerv Ment Dis 14: 541–554.

3. SandhoffK, AndreaeU, JatzkewitzH (1968) Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci 7: 283–288.

4. SvennerholmL (1962) The chemical structure of normal human brain and Tay-Sachs gangliosides. Biochem Biophys Res Commun 9: 436–441.

5. MakitaA, YamakawaT (1963) The glycolipids of the brain of Tay-Sachs' disease. The chemical structures of globoside and main ganglioside. Jpn J Exp Med 33: 361–368.

6. LedeenR, SalsmanK (1965) Structure of the Tay-Sachs' ganglioside. Biochemistry 4: 2225–2233.

7. BleyAE, GiannikopoulosOA, HaydenD, KubilusK, TifftCJ, et al. (2011) Natural history of infantile G(M2) gangliosidosis. Pediatrics 128: e1233–1241.

8. SmithNJ, WinstoneAM, StellitanoL, CoxTM, VerityCM (2012) GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed. Dev Med Child Neurol 54: 176–182.

9. Schneck L (1964) The clinical aspects of Tay-Sachs disease. In: BWVolk, editor. Tay-Sachs' Disease. New York: Grune and Stratton. pp. 16–35.

10. SangoK, YamanakaS, HoffmannA, OkudaY, GrinbergA, et al. (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11: 170–176.

11. PhaneufD, WakamatsuN, HuangJQ, BorowskiA, PetersonAC, et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5: 1–14.

12. GossenM, BujardH (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547–5551.

13. YamamotoA, LucasJJ, HenR (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101: 57–66.

14. SantacruzK, LewisJ, SpiresT, PaulsonJ, KotilinekL, et al. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309: 476–481.

15. LopezME, KleinAD, DimbilUJ, ScottMP (2011) Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J Neurosci 31: 4367–4378.

16. NorflusF, YamanakaS, ProiaRL (1996) Promoters for the human beta-hexosaminidase genes, HEXA and HEXB. DNA Cell Biol 15: 89–97.

17. RalphGS, BienemannA, HardingTC, HoptonM, HenleyJ, et al. (2000) Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors. Neuroreport 11: 2051–5.

18. SchochS, CibelliG, ThielG (1996) Neuron-specific gene expression of synapsin I. Major role of a negative regulatory mechanism. J Biol Chem 271: 3317–3323.

19. ChungJH, BellAC, FelsenfeldG (1997) Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci U S A 94: 575–580.

20. Hogan B, Beddington R, Costantini F, Lacy E (1994) Manipulating the mouse embryo, a laboratory manual (second edition). New York: Cold Spring Harbor Laboratory Press.

21. Cachón-GonzálezMB, WangSZ, LynchA, ZieglerR, ChengSH, CoxTM (2006) Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci U S A 103: 10373–10378.

22. LacorazzaHD, JendoubiM (1995) In situ assessment of beta-hexosaminidase activity. Biotechniques 19: 434–440.

23. Cachón-GonzálezMB, WangSZ, McNairR, BradleyJ, LunnD, et al. (2012) Gene Transfer Corrects Acute GM2 Gangliosidosis-Potential Therapeutic Contribution of Perivascular Enzyme Flow. Mol Ther 27 March [E-pub ahead of print].

24. HickmanS, ShapiroLJ, NeufeldEF (1974) A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts. Biochem Biophys Res Commun 57: 55–61.

25. ChtartoA, BenderHU, HanemannCO, KempT, LehtonenE, et al. (2003) Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther 10: 84–94.

26. MizuguchiH, HayakawaT (2002) The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector. J Gene Med 4: 240–247.

27. HofmannA, NolanGP, BlauHM (1996) Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci U S A 93: 5185–5190.

28. MiyazakiS, MiyazakiT, TashiroF, YamatoE, MiyazakiJ (2005) Development of a single-cassette system for spatiotemporal gene regulation in mice. Biochem Biophys Res Commun 338: 1083–1088.

29. MasuiS, ShimosatoD, ToyookaY, YagiR, TakahashiK, et al. (2005) An efficient system to establish multiple embryonic stem cell lines carrying an inducible expression unit. Nucleic Acids Res 33: e43.

30. ShapovalovAI, GurevitchNR (1970) Monosynaptic and disynaptic reticulospinal actions on lumbar motoneurons of the rat. Brain Res 21: 249–263.

31. PetersonBW, PittsNG, FukushimaK (1979) Reticulospinal connections with limb and axial motoneurons. Exp Brain Res 36: 1–20.

32. RiddleCN, EdgleySA, BakerSN (2009) Direct and indirect connections with upper limb motoneurons from the primate reticulospinal tract. J Neurosci 29: 4993–4999.

33. CroneC, PetersenNT, NielsenJE, HansenNL, NielsenJB (2004) Reciprocal inhibition and corticospinal transmission in the arm and leg in patients with autosomal dominant pure spastic paraparesis (ADPSP). Brain 127: 2693–2702.

34. NielsenJB, CroneC, HultbornH (2007) The spinal pathophysiology of spasticity–from a basic science point of view. Acta Physiol (Oxf) 189: 171–180.

35. SargeantTJ, WangS, BradleyJ, SmithNJ, RahaAA, et al. (2011) Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain. Hum Mol Genet 20: 4371–4380.

36. MolonA, Di GiovanniS, HathoutY, NataleJ, HoffmanEP (2006) Functional recovery of glycine receptors in spastic murine model of startle disease. Neurobiol Dis 21: 291–304.

37. HalleyDJ, de Wit-VerbeekHA, ReuserAJ, GaljaardH (1978) The distribution of hydrolytic enzyme activities in human fibroblast cultures and their intercellular transfer. Biochem Biophys Res Commun 82: 1176–1182.

38. AndersK, BuschowC, CharoJ, BlankensteinT (2011) Depot formation of doxycycline impairs Tet-regulated gene expression in vivo. Transgenic Res In press.

39. KrestelHE, ShimshekDR, JensenV, NevianT, KimJ, et al. (2004) A Genetic Switch for Epilepsy in Adult Mice. J Neurosci 24: 10568–10578.

40. BejarR, YasudaR, KrugersH, HoodK, MayfordM (2002) Transgenic calmodulin-dependent protein kinase II activation: dose-dependent effects on synaptic plasticity, learning, and memory. J Neurosci 22: 5719–5726.

41. ZhuP, AllerMI, BaronU, CambridgeS, BausenM, et al. (2007) Silencing and un-silencing of tetracycline-controlled genes in neurons. PLoS ONE 2: e533 doi:10.1371/journal.pone.0000533.

42. PankiewiczR, KarlenY, ImhofMO, MermodN (2005) Reversal of the silencing of tetracycline-controlled genes requires the coordinate action of distinctly acting transcription factors. J Gene Med 7: 117–132.

43. NgamukoteS, YanagisawaM, ArigaT, AndoS, YuRK (2007) Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem 103: 2327–2341.

44. YuRK, MacalaLJ, TakiT, WeinfieldHM, YuFS (1988) Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem 50: 1825–1829.

45. ZervasM, WalkleySU (1999) Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development. J Comp Neurol 413: 429–448.

46. GoodmanLA, WalkleySU (1996) Elevated GM2 ganglioside is associated with dendritic proliferation in normal developing neocortex. Brain Res Dev Brain Res 93: 162–171.

47. WalkleySU, SiegelDA, DobrenisK (1995) GM2 ganglioside and pyramidal neuron dendritogenesis. Neurochem Res 20: 1287–1299.

48. YuT, ShakkottaiVG, ChungC, LiebermanAP (2011) Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum Mol Genet 20: 4440–4451.

49. ManfredssonFP, BurgerC, RisingAC, Zuobi-HasonaK, SullivanLF, et al. (2009) Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. Mol Ther 17: 1857–1867.